Endometrial cancer is the sixth most common cancer and the fourth leading cause of death amongst women worldwide. Currently there are no screening strategies successfully implemented in clinical practice for the general population. Present diagnostic approaches are invasive, costly and time consuming. Here, we present results of a simple blood test showing promise for endometrial cancer detection. Both Raman and FtIR-ATR (Fourier transform Infrared Attenuated Total Reflection) spectroscopies, of blood plasma taken from patients with and without endometrial cancer, as ascertained by histopathology, are shown to yield discrimination of endometrial cancer. Spectral data classification is performed using Quasar open-source software.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.